Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,310
archived clinical trials in
Allergy

A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Chesapeake Clinical Research, Inc
mi
from
Baltimore, MD
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Updated: 1/1/1970
Chesapeake Clinical Research, Inc
mi
from
Baltimore, MD
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Respiratory Medicine Research Institute of Michigan
mi
from
Ypsilanti, MI
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Updated: 1/1/1970
Respiratory Medicine Research Institute of Michigan
mi
from
Ypsilanti, MI
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Clinical Research Institute Inc.
mi
from
Minneapolis, MN
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Updated: 1/1/1970
Clinical Research Institute Inc.
mi
from
Minneapolis, MN
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
The Asthma & Allergy Center, P.C.
mi
from
Papillion, NE
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Updated: 1/1/1970
The Asthma & Allergy Center, P.C.
mi
from
Papillion, NE
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Princeton Center for Clinical Research
mi
from
Skillman, NJ
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Updated: 1/1/1970
Princeton Center for Clinical Research
mi
from
Skillman, NJ
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Asthma, Sinus & Allergy Centers, LLC
mi
from
Warren, NJ
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Updated: 1/1/1970
Asthma, Sinus & Allergy Centers, LLC
mi
from
Warren, NJ
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Island Medical Research
mi
from
Rockville Center, NY
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Updated: 1/1/1970
Island Medical Research
mi
from
Rockville Center, NY
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
North Carolina Clinical Research
mi
from
Meredith, NC
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Updated: 1/1/1970
North Carolina Clinical Research
mi
from
Meredith, NC
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Bernstein Clinical Research Center
mi
from
Cincinnati, OH
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Updated: 1/1/1970
Bernstein Clinical Research Center
mi
from
Cincinnati, OH
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Toledo Center for Clinical Research
mi
from
Sylvania, OH
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Updated: 1/1/1970
Toledo Center for Clinical Research
mi
from
Sylvania, OH
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Oklahoma Institute of Allergy and Asthma
mi
from
Oklahoma City, OK
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Updated: 1/1/1970
Oklahoma Institute of Allergy and Asthma
mi
from
Oklahoma City, OK
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Allergy, Asthma and clinical Research Center
mi
from
Oklahoma City, OK
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Updated: 1/1/1970
Allergy, Asthma and clinical Research Center
mi
from
Oklahoma City, OK
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Baker Allergy, Asthma and Dermatology Research Center
mi
from
Lake Oswego, OR
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Updated: 1/1/1970
Baker Allergy, Asthma and Dermatology Research Center
mi
from
Lake Oswego, OR
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Allergy Associated Research Center
mi
from
Portland, OR
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Updated: 1/1/1970
Allergy Associated Research Center
mi
from
Portland, OR
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Allergy and Asthma Consultants of NJ-PA, P.C
mi
from
Collegeville, PA
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Updated: 1/1/1970
Allergy and Asthma Consultants of NJ-PA, P.C
mi
from
Collegeville, PA
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Allergy and Asthma Consultants, LLP
mi
from
Charleston, SC
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Updated: 1/1/1970
Allergy and Asthma Consultants, LLP
mi
from
Charleston, SC
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Isis Clinical Research, LLC
mi
from
Austin, TX
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Updated: 1/1/1970
Isis Clinical Research, LLC
mi
from
Austin, TX
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Central Texas Clinical Research
mi
from
Austin, TX
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Updated: 1/1/1970
Central Texas Clinical Research
mi
from
Austin, TX
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Sirius Clinical Research, LLC
mi
from
Austin, TX
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Updated: 1/1/1970
Sirius Clinical Research, LLC
mi
from
Austin, TX
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Pharmaceutical Research and Consulting, Inc
mi
from
Dallas, TX
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Updated: 1/1/1970
Pharmaceutical Research and Consulting, Inc
mi
from
Dallas, TX
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Western Sky Medical Research
mi
from
El Paso, TX
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Updated: 1/1/1970
Western Sky Medical Research
mi
from
El Paso, TX
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Sylvana Research Associates
mi
from
San Antonio, TX
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Updated: 1/1/1970
Sylvana Research Associates
mi
from
San Antonio, TX
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Intermountain Clinical Research
mi
from
Draper, UT
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Updated: 1/1/1970
Intermountain Clinical Research
mi
from
Draper, UT
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Marycliff Allergy Specialist
mi
from
Spokane, WA
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Updated: 1/1/1970
Marycliff Allergy Specialist
mi
from
Spokane, WA
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Gary Steven, MD
mi
from
Greenfield, WI
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 (0.15% Solution) and MP03-33 (0.10% Solution) in Children Ages >6 to <12 With Perennial Allergic Rhinitis
Status: Archived
Updated: 1/1/1970
Gary Steven, MD
mi
from
Greenfield, WI
A Comparison of Skin Prick Tests, Clinical Symptoms, and Nasal Challenge Using a New Mouse Extract
A Comparison of Skin Prick Tests, Clinical Symptoms and Nasal Challenge Using a New Mouse Extract
Status: Archived
Clinical Research Center at Vanderbilt University
mi
from
Nashville, TN
A Comparison of Skin Prick Tests, Clinical Symptoms, and Nasal Challenge Using a New Mouse Extract
A Comparison of Skin Prick Tests, Clinical Symptoms and Nasal Challenge Using a New Mouse Extract
Status: Archived
Updated: 1/1/1970
Clinical Research Center at Vanderbilt University
mi
from
Nashville, TN
Acupressure in Pruritus for Atopic Dermatitis
Evaluating the Effectiveness of Acupressure in Relieving Pruritus Related to Atopic Dermatitis
Status: Archived
Northwestern University
mi
from
Chicago, IL
Acupressure in Pruritus for Atopic Dermatitis
Evaluating the Effectiveness of Acupressure in Relieving Pruritus Related to Atopic Dermatitis
Status: Archived
Updated: 1/1/1970
Northwestern University
mi
from
Chicago, IL
Vitamin D Plus Fluticasone Propionate
The Addition of Vitamin D to Fluticasone Propionate in the Management of Seasonal Allergic Rhinitis
Status: Archived
University of Chicago
mi
from
Chicago, IL
Vitamin D Plus Fluticasone Propionate
The Addition of Vitamin D to Fluticasone Propionate in the Management of Seasonal Allergic Rhinitis
Status: Archived
Updated: 1/1/1970
University of Chicago
mi
from
Chicago, IL
Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Pediatric Patients
Status: Archived
Alcon Call Center
mi
from
Fort Worth, TX
Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Pediatric Patients
Status: Archived
Updated: 1/1/1970
Alcon Call Center
mi
from
Fort Worth, TX
AL-817 and AL-4943A for the Treatment of Allergic Conjunctivitis
Status: Archived
Alcon Call Center
mi
from
Fort Worth, TX
AL-817 and AL-4943A for the Treatment of Allergic Conjunctivitis
Status: Archived
Updated: 1/1/1970
Alcon Call Center
mi
from
Fort Worth, TX
Yulex Glove Prospective Study in Spina Bifida
Yulex Glove Prospective Study
Status: Archived
Hugo W. Moser Research Institute at Kennedy Krieger Inc.
mi
from
Baltimore, MD
Yulex Glove Prospective Study in Spina Bifida
Yulex Glove Prospective Study
Status: Archived
Updated: 1/1/1970
Hugo W. Moser Research Institute at Kennedy Krieger Inc.
mi
from
Baltimore, MD
Patient Perception Study of AL-4943A
Status: Archived
Alcon Call Center
mi
from
Fort Worth, TX
Patient Perception Study of AL-4943A
Status: Archived
Updated: 1/1/1970
Alcon Call Center
mi
from
Fort Worth, TX
Safety of Epicutaneous Immunotherapy for the Treatment of Peanut Allergy
Epicutaneous Immunotherapy (EPIT) for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Safety Study in Adult and Pediatric Subjects
Status: Archived
Arkansas Children's Hospital
mi
from
Little Rock, AR
Safety of Epicutaneous Immunotherapy for the Treatment of Peanut Allergy
Epicutaneous Immunotherapy (EPIT) for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Safety Study in Adult and Pediatric Subjects
Status: Archived
Updated: 1/1/1970
Arkansas Children's Hospital
mi
from
Little Rock, AR
Safety of Epicutaneous Immunotherapy for the Treatment of Peanut Allergy
Epicutaneous Immunotherapy (EPIT) for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Safety Study in Adult and Pediatric Subjects
Status: Archived
National Jewish Health
mi
from
Denver, CO
Safety of Epicutaneous Immunotherapy for the Treatment of Peanut Allergy
Epicutaneous Immunotherapy (EPIT) for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Safety Study in Adult and Pediatric Subjects
Status: Archived
Updated: 1/1/1970
National Jewish Health
mi
from
Denver, CO
Safety of Epicutaneous Immunotherapy for the Treatment of Peanut Allergy
Epicutaneous Immunotherapy (EPIT) for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Safety Study in Adult and Pediatric Subjects
Status: Archived
CRI Worldwide
mi
from
Mt Laurel, NJ
Safety of Epicutaneous Immunotherapy for the Treatment of Peanut Allergy
Epicutaneous Immunotherapy (EPIT) for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Safety Study in Adult and Pediatric Subjects
Status: Archived
Updated: 1/1/1970
CRI Worldwide
mi
from
Mt Laurel, NJ
Safety of Epicutaneous Immunotherapy for the Treatment of Peanut Allergy
Epicutaneous Immunotherapy (EPIT) for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Safety Study in Adult and Pediatric Subjects
Status: Archived
Duke Univ Med Ctr
mi
from
Durham, NC
Safety of Epicutaneous Immunotherapy for the Treatment of Peanut Allergy
Epicutaneous Immunotherapy (EPIT) for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Safety Study in Adult and Pediatric Subjects
Status: Archived
Updated: 1/1/1970
Duke Univ Med Ctr
mi
from
Durham, NC
Safety of Epicutaneous Immunotherapy for the Treatment of Peanut Allergy
Epicutaneous Immunotherapy (EPIT) for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Safety Study in Adult and Pediatric Subjects
Status: Archived
Aspen Clinical Research, LLC
mi
from
Orem, UT
Safety of Epicutaneous Immunotherapy for the Treatment of Peanut Allergy
Epicutaneous Immunotherapy (EPIT) for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Safety Study in Adult and Pediatric Subjects
Status: Archived
Updated: 1/1/1970
Aspen Clinical Research, LLC
mi
from
Orem, UT
Safety and Efficacy of Bepotastine Besilate Ophthalmic Solution in Allergic Conjunctivitis Patients
Status: Archived
ISTA Pharmaceuticals, Inc.
mi
from
Irvine, CA
Safety and Efficacy of Bepotastine Besilate Ophthalmic Solution in Allergic Conjunctivitis Patients
Status: Archived
Updated: 1/1/1970
ISTA Pharmaceuticals, Inc.
mi
from
Irvine, CA
Subcutaneous Immunotherapy for Cockroach (SCITCO)
A Biomarker-Based Pilot Study of Cockroach Subcutaneous Immunotherapy in Cockroach Sensitive Adults With Asthma and/or Perennial Allergic Rhinitis
Status: Archived
Johns Hopkins Hosp
mi
from
Baltimore, MD
Subcutaneous Immunotherapy for Cockroach (SCITCO)
A Biomarker-Based Pilot Study of Cockroach Subcutaneous Immunotherapy in Cockroach Sensitive Adults With Asthma and/or Perennial Allergic Rhinitis
Status: Archived
Updated: 1/1/1970
Johns Hopkins Hosp
mi
from
Baltimore, MD
Topical Allstate and Nasal Allergen Challenge
A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial of Topical Allstate in the Prevention of the Signs and Symptoms of the Acute Response to Nasal Allergen Challenge (CETALY0001)
Status: Archived
University of Chicago
mi
from
Chicago, IL
Topical Allstate and Nasal Allergen Challenge
A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial of Topical Allstate in the Prevention of the Signs and Symptoms of the Acute Response to Nasal Allergen Challenge (CETALY0001)
Status: Archived
Updated: 1/1/1970
University of Chicago
mi
from
Chicago, IL
Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in Adults
An Open-Label Pilot Study to Determine the Efficacy and Tolerability of a Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis With Associated Pruritus in Adults
Status: Archived
Dermatology Consulting Services
mi
from
High Point, NC
Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in Adults
An Open-Label Pilot Study to Determine the Efficacy and Tolerability of a Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis With Associated Pruritus in Adults
Status: Archived
Updated: 1/1/1970
Dermatology Consulting Services
mi
from
High Point, NC
Effect of Olopatadine on Allergic Tear Mediators
Expression of Inflammatory Mediators in Allergic Conjunctivitis
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin
mi
from
Madison, WI
Effect of Olopatadine on Allergic Tear Mediators
Expression of Inflammatory Mediators in Allergic Conjunctivitis
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Broccoli Sprout Extract Effects on Allergic Inflammation in the Nose
Broccoli Sprout Extract Effects on the Inflammatory Response to Diesel Exhaust Particles in the Nose
Status: Enrolling
Updated:  12/31/1969
UCLA
mi
from
Los Angeles, CA
Broccoli Sprout Extract Effects on Allergic Inflammation in the Nose
Broccoli Sprout Extract Effects on the Inflammatory Response to Diesel Exhaust Particles in the Nose
Status: Enrolling
Updated: 12/31/1969
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Allergy Immunotherapy for the Reduction of Asthma
Efficacy of Allergy Immunotherapy in Preventing Asthma Morbidity in Atopic, Wheezing Children (Age 18 Months - 3 Years)
Status: Enrolling
Updated:  12/31/1969
Jacobi Medical Center
mi
from
Bronx, NY
Allergy Immunotherapy for the Reduction of Asthma
Efficacy of Allergy Immunotherapy in Preventing Asthma Morbidity in Atopic, Wheezing Children (Age 18 Months - 3 Years)
Status: Enrolling
Updated: 12/31/1969
Jacobi Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Management of Allergic Rhinitis Patients With Nasal Steroids and NeilMed® Sinus Rinse™ System With Isotonic Saline
Management of Allergic Rhinitis Patients With Nasal Steroids and NeilMed® Sinus Rinse™ System With Isotonic Saline: A Prospective Pilot Study
Status: Enrolling
Updated:  12/31/1969
Sinus Center - Medical Univesity of South Carolina
mi
from
Charleston, SC
Management of Allergic Rhinitis Patients With Nasal Steroids and NeilMed® Sinus Rinse™ System With Isotonic Saline
Management of Allergic Rhinitis Patients With Nasal Steroids and NeilMed® Sinus Rinse™ System With Isotonic Saline: A Prospective Pilot Study
Status: Enrolling
Updated: 12/31/1969
Sinus Center - Medical Univesity of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
A Pilot Study Using Anakinra/Kineret for the Treatment of Patients With Severe Atopic Dermatitis
A Pilot Study Using Anakinra/Kineret for the Treatment of Patients With Severe Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
A Pilot Study Using Anakinra/Kineret for the Treatment of Patients With Severe Atopic Dermatitis
A Pilot Study Using Anakinra/Kineret for the Treatment of Patients With Severe Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
FluMist in Egg Allergic Patients
Flu Vaccine in Egg-allergic Patients Minimizing Injections Safety Trial
Status: Enrolling
Updated:  12/31/1969
Walter Reed Army Medical Center
mi
from
Washington,
FluMist in Egg Allergic Patients
Flu Vaccine in Egg-allergic Patients Minimizing Injections Safety Trial
Status: Enrolling
Updated: 12/31/1969
Walter Reed Army Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Oral Peanut Immunotherapy
Oral Peanut Immunotherapy
Status: Enrolling
Updated:  12/31/1969
Food Allergy Center; Massachusetts General Hospital
mi
from
Boston, MA
Oral Peanut Immunotherapy
Oral Peanut Immunotherapy
Status: Enrolling
Updated: 12/31/1969
Food Allergy Center; Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Sublingual Immunotherapy for Peanut Allergy and Induction of Tolerance
Peanut Sublingual Immunotherapy and Induction of Clinical Tolerance in Peanut Allergic Children (SLIT Tolerance TLC) {Sublingual Immunotherapy for Peanut Allergy}
Status: Enrolling
Updated:  12/31/1969
Univ of North Carolina
mi
from
Chapel Hill, NC
Sublingual Immunotherapy for Peanut Allergy and Induction of Tolerance
Peanut Sublingual Immunotherapy and Induction of Clinical Tolerance in Peanut Allergic Children (SLIT Tolerance TLC) {Sublingual Immunotherapy for Peanut Allergy}
Status: Enrolling
Updated: 12/31/1969
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Immune Reactions in Contact Dermatitis Affected Skin
Analysis of Immune Reactions Occurring Upon Administration of Patch Tests and Contact Dermatitis Affected Skin
Status: Enrolling
Updated:  12/31/1969
Rockefeller University
mi
from
New York, NY
Immune Reactions in Contact Dermatitis Affected Skin
Analysis of Immune Reactions Occurring Upon Administration of Patch Tests and Contact Dermatitis Affected Skin
Status: Enrolling
Updated: 12/31/1969
Rockefeller University
mi
from
New York, NY
Click here to add this to my saved trials